Products and Services

Products and Services

Commercialized Active Pharmaceutical Ingredient


Ausun

Product Name

CAS Number

Specification

TP

DMF

Status

Abemaciclib

1231929-97-7

In-house

Q4 2025

Alectinib

1256580-46-7

In-house

Q4 2025

Apixaban

503612-47-3

In-house

Asenapine

65576-45-6

In-house

Avatrombopag

570406-98-3

In-house

Benzoxonium chloride

19379-90-9

In-house

Bicyclol

118159-48-1

CP, In-house

Bimatoprost

155206-00-1

In-house

Q3 2025

Binimetinib

606143-89-9

In-house

Q4 2025

Cabozantinib

849217-68-1

In-house

Q4 2025

Calcium Saccharate

5793-89-5

CP, In-house

Dabrafenib mesylate

1195768-06-9

In-house

Q4 2025

Dapagliflozin

461432-26-8

USP, In-house

Efinaconazole

164650-44-6

In-house

Eliglustat Tartrate

928659-70-5

In-house

Entecavir Monohydrate

209216-23-9

USP, EP, in-house

Febuxostat

144060-53-7

In-house

Fluvastatin sodium

93957-55-2

CP, USP, EP, JP

Galanthamine

357-70-0

EP, In-house

Q3 2025

Imatinib Mesylate

220127-57-1

EP, In-house

< 123 >